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CLINICAL MANIFESTATION AND LABORATORY 
FINDINGS AS PREDICTIVE FACTORS FOR DENGUE 
MORTALITY IN KOTA BHARU 
 
ABSTRACT 
 
Background: Dengue fever is an endemic disease in Malaysia. Changing of time made 
the classical clinical manifestation of dengue fever become vary and present a challenge 
in diagnosing and managing the patients. Warning signs and laboratory changes as 
describes in the WHO dengue guidelines 2009 are not usually present in every patient. 
We aim to identify the clinical manifestation and laboratory findings among the 
confirmed adults dengue-associated mortality patients in Kota Bharu Kelantan 
Malaysia.  
Methods: We conducted a case control study in all confirmed dengue death patients in 
Kota Bharu from January of 2005 till December 2015. All adult death patients were 
included and control was by computer-generated randomization. Four controls were 
chosen for every dengue-associated death case. Data were analysed by simple and 
multiple logistic regression.  
Results: Of 25 deaths, median age was 42 (SD ±14.5) years old. Male gender 
comprised of 56% and comorbidities existed in 60% of the cases.  Majority of patients 
sought treatment at the average of day 5 of fever. The warning sign that most patients 
had were nausea/ vomiting while the least was mucosal bleed. Laboratory abnormalities 
on admission included leucopenia (40%), leucocytosis (16%), raised urea (28%) and 
creatinine (36%). 80% of the dengue-associated mortality had thrombocytopenia during 
presentation with mean of 74.2 x 10
3
(SD ±62.61). Multiple logistic regression analysis 
showed two clinical manifestations were negatively associated with dengue-associated 
mortality – vomiting/nausea (adj. OR 0.13, 95% CI 0.02-0.76) and headache (adj.OR 
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0.15, 95% CI 0.03-0.86). Laboratory findings that were associated with dengue-
associated mortality were first TWC (adj. OR 1.82, 95% CI 1.08-3.05), second TWC 
(adj. OR 1.54, 95% CI 1.15-2.07), second platelet (adj. OR 0.97, 95% CI 0.95-0.99), 
urea (adj. OR 2.35, 95% CI 1.43-3.85) and creatinine (adj. OR 0.98, 95% CI 0.97-1.00).  
Conclusions: Dengue patients with vomiting/nausea and headache were the clinical 
manifestations of lower chance of having dengue-associated mortality. Laboratory 
findings of increasing in total white count and urea, reducing in platelet and creatinine 
were more likely to associate with dengue-associated mortality. Early detection of 
clinical deterioration and prompt treatment is the main key of prevention of death.  
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ABSTRAK 
 
Pengenalan: Deman denggi adalah penyakit endemic di Malaysia. Perubahan masa 
menyebabkan pertunjukkan klinikal deman denggi yang klasik menjadi berbeza dan 
menjadikannya sebagai satu cabaran dalam mendiagnosa dan merawat. Tanda-tanda 
amaran seperti yang digambarkan dalam garis panduan deman denggi WHO 2009 
adalah jarang ditunjukkan dalam setiap pesakit. Matlamat kami adalah untuk mengenal 
pasti pertunjukkan klinikal dan keputusan makmal di antara pesakit kematian demam 
denggi di kawasan Kota Bharu Kelantan Malaysia.   
Kaedah: Kami menjalankan satu kajian case control di antara semua pesakit yang telah 
disahkan kematian demam denggi di Kota Bharu daripada Januari 2005 hingga 
Disember 2015. Semua pesakit yang kematian denggi dimasukan dalam kajian dan kes 
kawalan dipilih secara rawak oleh komputer. Empat kes kawalan dipilih untuk setiap 
satu kes kematian. Data dianalisis dengan simple dan multiple logistic regression. 
Keputusan: Daripada 25 pesakit, median untuk umur ialah 42 tahun (SD ±14.5). Lelaki 
terdiri daripadda 56% dan yang mempunyai comorbid wujud dalam 60%. Majoriti 
pesakit mendapatkan rawatan dalam purata masa hari ke-lima demam. Tanda amaran 
yang ditunjukkan oleh kebanyakan pesakit adalah loya/muntah manakala yang paling 
sikit ialah pendarahan mukosa. Keputusan makmal yang tidak normal semasa 
kemasukan ke hospital termasuk leucopenia (40%), leukositosis (16%), kenaikan urea 
(28%) dan kreatinin (36%). 80% pesakit yang kematian denggi mempunyai 
thrombocytopenia semasa pertunjukkan dengan mean 74.2 x 10
3
(SD ±62.61). multiple 
logistic regression analisis menunjukkan dua pertunjukkan klinikal berkaitan dengan 
kematian demam denggi-loya/muntah ((adj. OR 0.13, 95% CI 0.02-0.76) dan sakit 
kepala (adj.OR 0.15, 95% CI 0.03-0.86). keputusan makmal yang berkaitan dengan 
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kematian denggi ialah TWC pertama (adj. OR 1.82, 95% CI 1.08-3.05), TWC kedua 
(adj. OR 1.54, 95% CI 1.15-2.07), platelet kedua (adj. OR 0.97, 95% CI 0.95-0.99), 
urea (adj. OR 2.35, 95% CI 1.43-3.85) and kreatinin (adj. OR 0.98, 95% CI 0.97-1.00). 
Kesimpulan: Pesakit yang menunjukan kemutahan dan sakit kepala mempunyai 
kemungkinan kematian yang rendah manakala peningkatan dalam bilangan sel darah 
putih dan urea, penurunan dalam platelet dan kreatinin menjadikan kemungkinan 
kematian meningkat. Pengesanan kemerosotan klinikal dan pemberian rawatan yang 
segera adalah kunci utama untuk mengelakan kematian.  
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1. INTRODUCTION 
Dengue viruses are mosquito-borne enveloped RNA viruses belonging to the 
family Flaviviridae in the genus Flavivirus. The new WHO classification for 
dengue severity is divided into dengue without warning sign, dengue with 
warning sign and severe dengue. According to WHO Western Pacific Region 
(WPRO), until 12 August 2014, cumulative number of reported cases in 
Malaysia is 53,246 and cumulative number of deaths reported is 147. Latest 
update from WPRO, for the week from 17 April to 23 April in 2016, the number 
of dengue cases was 1,607, a decrease from 1,854 cases reported in the previous 
week. The number of cases was higher than that reported during the same period 
in 2015. Within the same period there were two dengue-related deaths reported, 
bringing the total number of deaths for 2016 to 94, compared to a total of 120 
deaths during the same reporting period in 2015. Refer to Centers for Disease 
Control and Prevention (CDC), dengue is endemic in more than 110 countries 
and it is a leading cause of illness and death in the tropics and subtropics. It only 
emerged as a global issue since 1950s. 
Dengue virus (DENV) infection is a global disease which was affecting at least 
3.6 billion people living in more than 125 countries in the tropics and subtropics 
(Gubler 2012, Sam, Omar et al. 2013). In Malaysia, cases of dengue had 
increased from 15.2 per 100,000 in 1973 to 361.0 per 100,000 populations by 
the year 2014. At the same time, the mortality cases also went up from 0.16% to 
0.62% between 2000 to 2013 (Kadir, Mohamed et al. 2015). Kota Bharu area 
contributed almost 70% of the dengue fever cases in Kelantan (Hussin, Jaafar et 
al. 2005).  
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Dengue viruses are mosquito-borne enveloped RNA viruses belonging to the 
family Flaviviridae in the genus Flavivirus. Dengue virus is an envelope 
positive-sense RNA virus. It composed of 3 structural protein genes that encode 
the nucleocapsid or core protein (C), a membrane associated protein (M), an 
envelope protein (E) and seven non-structural (NS) protein genes (NS 1, NS 2A, 
NS 2B, NS 3, NS 4A, NS 4B, NS 5). Among that, NS 1 is an essential for the 
virus viability. 
 The new WHO classification for dengue severity is divided into dengue without 
warning sign, dengue with warning sign and severe dengue (Michael B. Nathan 
2009). As Malaysia is one of the endemic countries for dengue, diagnostic 
investigation is a must. There are a few diagnostic tests that are available, 
include antibody detection (serology), virus isolation, detection of virus genetic 
materials (polymerase chain reaction -PCR) and detection of dengue virus 
protein (NS1 antigen). A study in UMMC showed that the dengue deaths were 
seen primarily in adult females and were associated with secondary dengue 
infection (Sam, Omar et al. 2013). Changes in the climate, urbanization, rapid 
industrialization and economic growth and poor environmental cleanliness were 
the factors that cause rapid increase in the dengue cases (Mudin 2015). 
There were a number of reports reviewing the clinical manifestations and risk 
factors associated with the dengue fever and dengue-related deaths during the 
first two decades following the 1973 epidemic (Paramaesvaran 1965, George, 
Kassim et al. 1974, Wallace, Lim et al. 1980, Sam, Omar et al. 2013). In order to 
provide early and accurate management of the dengue patients and early public 
health notification and outbreaks control of dengue infection outbreaks, it is 
important to establish a diagnosis of acute dengue virus infection during the first 
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few days after manifestation of clinical symptoms. MOH Malaysia has come out 
with a method- Communication for Behavioural Impact (COMBI), it is an 
approach that can be utilized to mobilize communities for disease prevention. 
This approach is used to empower the people in dengue prone areas via 
mobilizing their community and resources in planning and implementing 
activities aimed at the prevention and control of dengue outbreaks in their area 
(Maimunah Bt A Hamid 2011).  
Currently, there is neither a vaccine to prevent the disease nor an antiviral 
treatment. However, secondary prevention to reduce mortality through improved 
clinical case management has substantially lowered the mortality rate for severe 
dengue over the past two decades from 10—20% to <1% (Sumarmo, Jahja et al. 
1983, Tran, Thanh Hung et al. 1998).  Early clinical feature of dengue fever is 
influenza-like fever. This makes clinical diagnosis a challenge. The usual 
symptom associated with fever was nausea and vomiting, followed by 
abdominal pain, rash, body aches, diarrhea, cough, hematemesis, bleeding gums, 
malena, altered mental status and jaundice (Almas, Parkash et al. 2010). Risk 
factors for fatality in patients with dengue infection have been identified in 
studies in the Americas (Guzmán, Kouri et al. 2002, Guzmán, Kourí et al. 2002, 
García-Rivera and Rigau-Pérez 2003, Rigau-Pérez and Laufer 2006, Cavalcanti, 
Coelho et al. 2010), Africa (Adam, Jumaa et al. 2010), Australia (McBride 
2005), Pacific islands (Barnes and Rosen 1974), South Asia (Raheel, Faheem et 
al. 2010, Juneja, Nasa et al. 2011) and Southeast Asia(Sumarmo, Jahja et al. 
1983, Magpusao, Monteclar et al. 2003, Anders, Nguyet et al. 2011, Lee, Liu et 
al. 2012). Even though, there were no definite symptoms and signs that could 
predict the outcome of the disease. Different area had different factors that 
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contributed to the mortality. In order to better understand and able to recognize 
the risk factors for mortality and the epidemiology of severe dengue cases in 
Hospital Universiti Sains Malaysia (HUSM) and Hospital Raja Perempuan 
Zainab II (HRPZ II) population, we conducted a case-control study of all dengue 
associated deaths within our institution and HRPZ II 
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2. OBJECTIVE 
 
The general objective of this study was to determine the associated factors between 
clinical features and laboratory findings in dengue mortality patients. 
The specific objectives were:  
1.  To describe the demographic data of dengue mortality cases in Kelantan  
2. To determine the association of clinical features in dengue-associated 
mortality patients 
3. To determine the association of laboratory results in dengue-associated 
mortality  patients 
4. To determine the percentage of platelet reduction between first sample and 
second sample (at least 6 hour apart) in dengue-associated mortality patients. 
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3. MANUSCRIPT 
The prepared manuscript is included in the following pages. The manuscript was 
prepared following MJMS journal format as attached at the end of the manuscript. 
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ABSTRACT 
Background: Dengue fever is an endemic disease in Malaysia. Changing of time made 
the classical clinical manifestation of dengue fever become vary and present a challenge 
in diagnosing and managing the patients. Warning signs and laboratory changes as 
described in the WHO dengue guidelines 2009 are not usually present in every patient. 
We aim to identify the clinical manifestation and laboratory findings among the 
confirmed adults dengue-associated mortality patients in Kota Bharu Kelantan 
Malaysia.  
Methods: We conducted a case control study in all confirmed dengue death patients in 
Kota Bharu from January of 2005 till December 2015. All adult death patients were 
included and control was by computer-generated randomization. Four controls were 
chosen for every dengue-associated death case. Data were analysed by simple and 
multiple logistic regression.  
Results: Of 25 deaths, median age was 42 (SD ±14.5) years old. Male gender 
comprised of 56% and comorbidities existed in 60% of the cases.  Majority of patients 
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sought treatment at the average of day 5 of fever. The warning sign that most patients 
had were nausea/ vomiting while the least was mucosal bleed. Laboratory abnormalities 
on admission included leucopenia (40%), leucocytosis (16%), raised urea (28%) and 
creatinine (36%). 80% of the dengue-associated mortality had thrombocytopenia during 
presentation with mean of 74.2 x 10
3
(SD ±62.61). Multiple logistic regression analysis 
showed two clinical manifestations were negatively associated with dengue-associated 
mortality – vomiting/nausea (adj. OR 0.13, 95% CI 0.02-0.76) and headache (adj.OR 
0.15, 95% CI 0.03-0.86). Laboratory findings that were associated with dengue-
associated mortality were first TWC (adj. OR 1.82, 95% CI 1.08-3.05), second TWC 
(adj. OR 1.54, 95% CI 1.15-2.07), second platelet (adj. OR 0.97, 95% CI 0.95-0.99), 
urea (adj. OR 2.35, 95% CI 1.43-3.85) and creatinine (adj. OR 0.98, 95% CI 0.97-1.00).  
Conclusions: Dengue patients with vomiting/nausea and headache were the clinical 
manifestations of lower chance of having dengue-associated mortality. Laboratory 
findings of increasing in total white count and urea, reducing in platelet and creatinine 
were more likely to associate with dengue-associated mortality. Early detection of 
clinical deterioration and prompt treatment is the main key of prevention of death.  
Key words: clinical manifestation, laboratory findings, dengue fever, mortality, Kota 
Bharu 
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Background 
 
Dengue virus (DENV) infection is a global disease which was affecting at least 3.6 
billion people living in more than 125 countries in the tropics and subtropics (1). In 
Malaysia, cases of dengue had increased from 15.2 per 100,000 in 1973 to 361.0 per 
100,000 populations by the year 2014. At the same time, the mortality cases also went 
up from 0.16% to 0.62% between 2000 to 2013 (2). Total 1701 dengue cases in whole 
Malaysia were reported from 25 September till 1 October 2016. Throughout January 
2016 till October 2016, 83224 cases were recorded compare with 91822 cases in year 
2015. Kelantan is among the highest number of dengue cases, which was after Selangor, 
Johor and Kuala Lumpur (3).  
Changes in the climate, urbanization, rapid industrialization and economic growth and 
poor environmental cleanliness were the factors that causing rapid increasing of the 
dengue cases (4). Study showed that dengue-related death is about 0.002% since 2001 
(5). There were  reports reviewing the clinical manifestations and risk factors associated 
with dengue fever and dengue-related deaths during the first two decades following the 
1973 epidemic (6). A study in Universiti Malaya Medical Centre showed that the 
dengue deaths were seen primarily in adult females and were associated with secondary 
dengue infection (7). 
In order to provide early and accurate management of the dengue patients and early 
public health notification and control of dengue infection outbreaks, it is important to 
prevent the dengue cases in the community and establish a diagnosis of acute dengue 
virus infection in healthcare facilities. MOH Malaysia has come out with a method - 
Communication for Behavioural Impact (COMBI), it is an approach that can be utilized 
to mobilize communities for disease prevention. This approach is used to empower the 
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people in dengue prone areas via mobilizing their community and resources in planning 
and implementing activities aimed at the prevention and control of dengue outbreaks in 
their area (8). Currently, there is neither a vaccine to prevent the disease nor an antiviral 
treatment. However, secondary prevention to reduce mortality through improved 
clinical case management has substantially lowered the mortality rate for severe dengue 
over the past two decades from 10—20% to <1% (9).  The usual symptom associated 
with fever was nausea and vomiting, followed by abdominal pain, rash, body aches, 
diarrhea, cough, hematemesis, bleeding gums, malena, altered mental status and 
jaundice (10). Risk factors for fatality in patients with dengue infection have been 
identified in studies in the Americas (11), Africa (12), Australia (13), Pacific islands 
(14), and South Asia (15). Even though, there were no definite symptoms and signs that 
could predict the outcome of the disease. Different area had different factors that 
contributed to the mortality. In order to better understand and able to recognise the risk 
factors for mortality and the epidemiology of severe dengue cases in Hospital Universiti 
Sains Malaysia (HUSM) and Hospital Raja Perempuan Zainab II (HRPZ II) population, 
we conducted a case-control study of all dengue associated mortality  within our 
institution and HRPZ II. 
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Materials and methods 
 
A case-control study was performed. All cases of dengue-associated mortality in 
HUSM and HRPZ II for the period year 2005 to 2015 were identified through Jabatan 
Kesihatan Negeri Kelantan (JKNK) included  those cases referred from other state and 
died at HRPZ II or HUSM. Paediatric patients and who were diagnosed dengue fever 
but cause of death was secondary to non-dengue fever were excluded from this study. 
Not all the cases from the year 2005 to 2015 were selected because of missing files and 
some were destroyed during the largest recorded flood in Kelantan history where HRPZ 
II was badly affected and had to close the hospital (16). This study was approved by 
Human Research Committee USM (HREC) and Medical Research and Ethics 
Committee Ministry of Health Malaysia. HUSM is a-783 bed tertiary care centre while 
HRPZ II is a-920 bed tertiary centre. 
All cases of dengue were defined as: (i) a compatible clinical illness with (ii) 
positive serology (IgM and/or IgG by immunocromatographic test (2014 onward) or 
ELISA (before 2014) or iii) NS 1 antigen. Dengue- associated mortality was defined as 
deaths resulting from, and as a direct consequence of acute dengue infection. Patients 
admitted with dengue virus infection from year 2005 to 2015 were selected from the 
HUSM and HRPZ II patient database as controls. Four controls were chosen for every 
dengue-associated mortality case. The medical records of all cases identified were 
reviewed. Final disease categorization into dengue fever without warning signs, dengue 
with warning signs and severe dengue, based on the World Health Organization’s 
recommended system of classification (WHO 2009). Duration of illness (day 1 of 
illness was counted as the day of fever onset), demographic, clinical, and laboratory 
data were collected on standardized data-collection forms. Petechiae, epistaxis and 
gingival bleeding were classified as minor bleeding complications. First full blood 
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count (TWC, platelet, haematocrit and haemoglobin) was taken upon arrival to the 
emergency department (ED) HUSM or HRPZ II. Second platelet was selected based on 
timing of subsequent full blood count taken which was at least 6 hours apart from the 
first full blood count.  
Data were entered into SPSS version 22 software. The descriptive results for 
categorical variables were displayed by frequency and percentage. For continuous 
variables, mean and standard deviation were used. Certain variables were excluded from 
the univariate analysis such as lethargic, chest pain, convulsion, full blood count before 
treatment at ED, creatine kinase, coagulation profile, bicarbonate level, serum lactate, 
capillary blood sugar and the difference of platelet count between platelet before arrival 
referral to ED and arrival in the ED due to large number of missing values. There were 
25 readily available biodata, clinical parameters and laboratory results (age, duration of 
illness, vomiting/nausea, abdominal pain, mucosal bleed, headache, myalgia, arthralgia, 
hepatomegaly, cold periphery, dehydration, rashes, pulse volume, systolic blood 
pressure, diastolic blood pressure, first TWC, second TWC, first platelet count, second 
platelet count,  first haematocrit, second haematocrit, urea, creatinine, different between 
first and second platelet and percentage of reduction between first and second platelet) 
with p<0.25 and clinically significant from univariate analysis were put into the 
multivariate model. Level of significant set at 2 tailed p-value of <0.25. 
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Results 
 
 Table 1: Demographic of dengue mortality and uncomplicated cases 
 
Variable Mortality-associated group       
(n=25) 
n (%) 
Uncomplicated DF  
(n = 100) 
n (%) 
Age (years)* 42.4 (14.5) 32.6 (15.0) 
Ethnicity Malay  22 (88.0) 96 (96.0) 
Chinese 3 (12.0) - 
Indian - 1 (1.0) 
Others  - 3 (3.0) 
Sex  Male  14 (56.0) 49 (49.0) 
Female  11 (44.0) 51 (51.0) 
Location   Kota Bharu 17 (68.0) 71 (71.0) 
Pasir Puteh 1 (4.0) 2 (2.0) 
Bachok 1 (4.0) 18 (18.0) 
Machang 1 (4.0) - 
Kuala Krai 2 (8.0) - 
Pasir Mas 2 (8.0) 4 (4.0) 
Tumpat 1 (4.0) 5 (5.0) 
Medical illness  DM 4 (16.0) 4 (4.0) 
HPT 7 (28.0) 10 (10.0) 
BA 2 (8.0) 3 (3.0) 
COAD 1 (4.0) 1 (1.0) 
IHD 2 (8.0) 1 (1.0) 
Others  5 (20.0) 5 (5.0) 
Fever  24 (96) 100 (100) 
Duration of  
fever (day) 
1 0 (0.0) 3 (3.0) 
2 3 (12.0) 12 (12.0) 
3 5 (20.0) 13 (13.0) 
4 5 (20.0) 23 (23.0) 
5 9 (36.0) 19 (19.0) 
≥6 2 (8.0) 28 (28.0) 
 
*Mean (SD) 
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Table 2: Presenting symptoms of dengue mortality and uncomplicated cases 
 
Variable  Mortality-associated 
Group (n=25) 
n (%) 
Uncomplicated DF 
(n = 100) 
n (%) 
Vomit/nausea 12 (48) 70 (70) 
Abdominal pain 6 (24) 42 (42) 
Mucosal bleed 2 (8) 10 (10) 
SOB 4 (16) 4(4) 
Diarrhea 7 (28) 31 (31) 
Cough 6 (24) 12 (12) 
Running nose 2 (8) 3 (3) 
Sore throat 2 (8) 4 (4) 
Headache 13 (52) 73 (73) 
Myalgia 19 (76) 86 (86) 
Arthralgia 16 (64) 79 (79) 
Retro-orbital pain 12 (48) 38 (38) 
Hepatomegaly 9 (36) 7 (7) 
Cold periphery 11 (44) 11 (11) 
Dehydration 16 (64) 47 (47) 
Rashes 3 (12) 22 (22) 
Poor Pulse volume 5 (20) 1 (1) 
Prolonged CRT 4 (16) 3 (3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
Table 3: Presenting signs and laboratory results of dengue mortality and uncomplicated 
cases 
 
 
Variable  Mortality-associated group  
(n=25) 
Uncomplicated DF (n = 100) 
Mean (SD) Range  Mean (SD) Range  
Duration of illness 7.6 (2.47) 3-13 7.9 (1.93) 3-14 
Heart rate 102.6 (23.32) 61-137 89.5 (18.17) 45-135 
Respiratory rate 23.0 (4.82) 17-36 19.8 (2.51) 12-32 
SBP 112.6 (24.29) 52-164 117.6 (16.59) 88-180 
DBP 68.1 (12.13) 32-95 72.6 (12.36) 40-100 
Pulse pressure 44.0 (15.76) 18-72 44.6 (12.87) 16-102 
Temperature 37.9 (1.05) 36.8-41.1 37.9 (0.89) 36.2-40.0 
First TWC 5.9 x 10
9
 
(3.81)
 
1.6-16.7 x 
10
9
 
3.6 x 10
9
(1.64)
 
1.4-10.3 x 
10
9
 
Second TWC 7.3 x 10
9
 
(5.91) 
1.3-24.7 x 
10
9
 
3.5 x 10
9
(1.56)
 
1.3-9.0 x 10
9
 
First platelet 74.2 
x10
3
(62.61) 
0-205 x 10
3
  103.7 x 10
3
 
(59.49) 
1-294 x 10
3
 
Second platelet 57.8 x 10
3
 
(54.21) 
1-177 x 10
3
 89.2 x 10
3
  
(55.80) 
7-266 x 10
3
 
First HCT 41.4 (8.57) 20.1-54.2 41.0 (4.82) 24.0-53.7 
Second HCT 39.7 (6.89) 23.4-50.7 39.6 (4.41) 24.9-49.5 
First Hb 14.1 (3.13) 6.9-19.8 14.0 (1.96) 4.2-18.6 
Second Hb 13.5 (2.62) 7.6-18 13.5 (1.69) 8.4-17.9 
Urea 8.0 (6.07) 2.5-25.9 4.3 (3.33) 1.3-31.5 
Creatinine 150.7 
(154.09) 
53-804 93.6 (106.14) 3-1109 
Albumin 32.4 (11.60) 14-75 37.9 (5.90) 4-52 
AST 421.4 
(727.17) 
5-3497 141.2 (165.04) 18-933 
ALT 481.7 
(1076.49) 
12-4500 91.9 (97.52) 7-538 
ALP 160.1 
(123.51) 
18-519 94.0 (53.72) 314-287 
Different platelet  16.4 (28.47) -46-89 14.9 (22.27) -35-105 
% different platelet 15.0 (39.21) -88.8-76.0 13.9 (24.39) -92.8-82.0 
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Table 4: Crude OR, 95% CI and p-value for univariate unadjusted binary logistic 
regression and multivariate adjusted binary logistic regression. 
Variable  Univariate analysis Multivariate analysis 
 Crude OR 
(95% CI) 
p-value Adjusted OR  
(95% Cl) 
P-value 
Age 1.04 (1.01,1.08) 0.005   
Sex  0.76 (0.31,1.82) 0.532   
Duration of illness 0.94 (0.38,1.17) 0.553   
Vomiting/nausea 0.40 (0.16,0.97) 0.420 0.13 (0.02,0.76) 0.023 
Abdominal pain 0.44 (0.16,1.19) 0.104   
Mucosal bleed 0.78 (0.16,3.82) 0.762   
SOB 4.00 (0.92,17.33) 0.640   
Diarrhea  0.82 (0.31,2.16) 0.681   
Cough 2.11 (0.70,6.33) 0.185   
Running nose 2.52 (0.40,15.99) 0.326   
Sore throat 1.83 (0.32,10.60) 0.502   
Headache  0.31 (0.12,0.78) 0.013 0.15 (0.03,0.86) 0.033 
Myalgia 0.48 (0.16,1.42) 0.184 0.25 (0.03,2.23) 0.215 
Arthalgia 0.43 (0.16,1.11) 0.082   
Retro-orbital pain 1.05 (0.43,2.56) 0.924   
Hepatomegaly 7.31 (2.38,22.45) <0.001   
Cold periphery 6.36 (2.32,17.42) <0.001   
Dehydration 2.01 (0.81,4.96) 0.132   
Rashes 0.48 (0.13,1.77) 0.272   
CRT 6.16 (1.28,29.59) 0.023   
Heart rate 1.03 (1.01,1.06) 0.004   
Respiratory rate 1.32 (1.13,1.55) <0.001   
SBP 0.99 (0.96,1.01) 0.226 0.92 (0.85,1.01) 0.068 
DBP 0.97 (0.94,1.01) 0.109 1.01 (0.91,1.12) 0.883 
Pulse pressure 0.99 (0.96,1.03) 0.841   
Temperature 0.97 (0.60,1.56) 0.887   
First TWC 1.45 (1.18,1.77) <0.001 1.82 (1.08,3.05) 0.024 
Second TWC 1.54 (1.23,1.94) <0.001 1.54 (1.15,2.07) 0.004 
First platelet 0.99 (0.98,0.99) 0.034   
Second platelet 0.99 (0.98,0.10) 0.018 0.97 (0.95,0.99) 0.005 
First HCT 1.01 (0.94,1.10) 0.764   
Second HCT 0.99 (0.96,1.03) 0.704   
First Hb 1.01 (0.83,1.24) 0.893   
Second Hb 1.00 (0.98,1.03) 0.930   
Urea 1.21 (1.06,1.39) 0.005 2.35 (1.43,3.85) 0.001 
Creatinine 1.00 (0.99,1.01) 0.097 0.98 (0.97,1.00) 0.008 
Albumin 0.90 (0.85,0.97) 0.003   
AST 1.00 (1.00,1.00) 0.006   
ALT 1.01 (1.00,1.01) 0.008   
ALP 1.01 (1.00,1.02) <0.001   
Different 1
st
 and 2
nd
 platelet 1.00 (0.98,1.02) 0.770   
% different 1
st
 and 2
nd
 0.99 (0.98,1.01) 0.695   
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From table 1, of the dengue-associated mortality cases, 14 (56.0%) were male with a 
mean age of 42.44, with the youngest was 17 and the oldest was 60, 11 were female 
(44.0%) with the mean age of 32.55, youngest age 23 while oldest age 64; 22 (88%) 
patients were Malay while Chinese comprised of 3 (12%) patients. Majority of them 
were originated from Kota Bharu which were 17 (68%) patients. 21 (84%) patients had 
comorbidity such as diabetes mellitus, hypertension, bronchial asthma, chronic 
obstructive pulmonary disease, ischemic heart disease and other illnesses. There was 
one afebrile dengue-associated mortality patient who presented to hospital with 
convulsion and low platelet. CT brain was done and was found to have intracranial 
haemorrhage and dengue confirmation was done by dengue serology which showed 
IgM positive. For the patients presented with fever, only 2 persons sought for treatment 
after 6 days of fever. 
 The criteria for admission of the dengue-associated mortality cases were 
compared to controls and shown in table 2 and 3. All controls were categorized as 
having uncomplicated dengue fever. Among the alarming signs, nausea/vomiting were 
the most presenting symptoms among the mortality patients, which was 48%. Followed 
by hepatomegaly, diarrhoea, abdominal pain and mucosal bleed which were 36%, 28%, 
24% and 8% respectively. . Signs of shock manifested by dehydration, cold periphery, 
poor pulse volume and prolonged CRT which were 64%, 44%, 20% and 16% 
respectively. The mean duration of illness till death was 7.6 day, ranging from 3-13 
days. Mean SBP was 112.56 mmHg (SD ±24.29) and mean DBP was 68.08 (SD 
±12.13). Only 3 patients were in hypotensive state during the presentation. More than 
50% of the patients had tachypnoeic (RR >20) with the mean respiratory rate was 22.96 
(SD ±4.82). During presentation, 11 patients (SD ±23.32) were tachycardia and more 
than half (60%) of them sought for treatment during the time of defervescence (Michael 
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B. Nathan 2009). Laboratory abnormalities on admission included leucopenia (40%), 
leucocytosis (16%), raised urea (28%) and creatinine (36%). 80% of the dengue-
associated mortality had thrombocytopenia during presentation with mean of  74.2 x 
10
3
(SD ±62.61).  Mean of different first platelet and second platelet count was 16.4 (SD 
±28.47). Based on univariate analysis, age, abdominal pain, cough, headache, myalgia, 
arthalgia, hepatomegaly, cold periphery, dehydration, abnormal CRT, heart rate, 
respiratory rate, systolic and diastolic blood pressure, first and second total white count, 
first and second platelet were statistically more frequent in mortality-associated cases. 
However multiple logistic regression analysis shows two clinical manifestations were 
negatively associated with dengue-associated mortality – vomiting/nausea (adj. OR 
0.13, 95% CI 0.02-0.76) and headache (adj.OR 0.15, 95% CI 0.03-0.86). Laboratory 
findings that were associated with dengue-associated mortality were first TWC (adj. OR 
1.82, 95% CI 1.08-3.05), second TWC (adj. OR 1.54, 95% CI 1.15-2.07), second 
platelet (adj. OR 0.97, 95% CI 0.95-0.99), urea (adj. OR 2.35, 95% CI 1.43-3.85) and 
creatinine (adj. OR 0.98, 95% CI 0.97-1.00). 
 
Discussion  
Dengue-associated mortality is about 2 to 3 in a thousand cases (5). Malaysia is 
not exceptional with the mortality of 336 cases in year 2015 from 28 persons in year 
2005 (17). Early diagnosis is crucial to control or minimize the mortality rate especially 
for those working as the first-line healthcare provider like emergency room doctors. 
Identifying the warning clinical manifestation and laboratory findings of dengue 
patients are also important to improve the diagnosis and hasten the treatment (18). 
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Male gender comprised the majority in the mortality group, which is 14 ( 56%) 
cases compare with female 11 (44%) cases. Age among the mortality cases was 42.4 
(SD ±14.5). Although in our study it did not showed significant, but it was consistent 
with a study in Singapore (19). While another study in Singapore also, dengue mortality 
is also predominatly male but the mean age is older, 59 years old (21).   
Among the clinical manifestation of dengue-associated mortality patients, 
headache and vomiting/nausea during admission to the ED have lower risk of mortality 
(85% vs 87%).  Another study in Malaysia also showed that vomiting is a risk factor of 
mortality (4). A case control study from the Kerala India found that altered sensorium (p 
= 0.002) and hypertension (p = 0.03) were associated with dengue mortality (20). While 
another study at Karachi, Pakistan, SGPT >300 mg/dl (p=0.008), bleeding (p<0.001), 
altered mental status (p<0.001) and shock (p<0.001) were significantly associated 
dengue death (10). A Singapore case-control study showed that early vomiting and  
hematocrit changed >20% concurrent with low platelet on admission should raised the 
doctor suspicion for dengue death (21). In our study, patients with vomiting/nausea 
during presentation to ED will have lesser risk of death, where this can be because of 
early seeking for treatment among those having nausea, vomiting and headache.  
From our study, the laboratory findings of first and second total white count, 
second platelet count, urea and creatinine on admission were found to be independently 
associated with dengue mortality. Total white count normally will be normal until the 
disease progress and it become leucopenia (22). Increase in total white count during 
presentation secondary to bacterial infection has been proposed as a predictor of death 
in dengue infection (23). Our results were comparable with the previous study. In our 
study, two samples of full blood count were taken. Both results showed that increase in 
total white count would increase the risk of mortality. In context with dengue mortality 
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cases, leucocytosis and platelet count between first presentation and prior to succumb 
were shown to be significant (24). Lymphocyte and monocyte counts for 24 hours prior 
to intensive care unit admission had shown significance higher compared to lymphocyte 
and monocyte counts at first presentation only (25). However there is no guideline 
stated the usage of antibiotic in dengue infection because it was difficult to differentiate 
between sepsis in dengue shock and dengue with severe organ dysfunction although 
delayed in initiate antibiotic will increase the risk of mortality in coinfected patients 
(26). 
Laboratory findings of thrombocytopenia has been shown to have higher risk of 
mortality (18). Our study showed risk of mortality increases by three percent in every 
1,000/ul reduction in platelet count, which is consistent with the study in the Kerala 
India. Thrombocytopenia reduces the ability of clot formation and can lead to 
intracranial haemorrhage but it does not cause by thrombocytopenia per se.  Deranged 
prothrombin time, disseminated intravascular coagulation, and hepatic dysfunction can 
contribute to the intracranial hemorrhage (27). Two samples of FBC were taken and 
only second FBC result of platelet count  showed significant findings based on 
multivariate analysis. It may be due to dynamic process of the disease as the immune 
responses such as cytokine overproduction and generation of autoantibody acting 
against platelets (28). However, there was no significant different of the percentage of 
platelet reduction between the first sample and second sample with the mean platelet 
different was 16.4 X 10
3
.  
Higher level of urea level may be a predictor of mortality (20). Bleeding and 
dehydration can be a cause of raise urea level (25). However, the urea level can be 
varied  among the patient with underlying chronic kidney disease. Our study showed the 
urea mean was higher in dengue-associated mortality patients compared to 
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uncomplicated dengue fever patient which was 8.0 (SD ±6.07) and 4.3 (SD ±3.33) 
respectively.  Multivariate analysis showed that every 1 mmol/l of increment of urea, 
the risk of mortality increases by 2.3 folds. This result is comparable with the other 
study which showed that risk of morality increase by three percent (25). This is possible 
due to increase complement-fixation of dengue antigen in high urea environment (29). 
However, our study comes to a different view about the creatinine.  Previous study had 
identified acute renal failure in about 80% of elderly dengue-associated mortality 
patient (30). Our study showed that 10 umol/l increased in creatinine decreased the odd 
of mortality by 16%. Early detection of renal failure and subsequently early intervention 
such as haemodialysis can be accomplished before deterioration. Anyway, further study 
is needed especially patient admitted to intensive care unit to determine the renal 
function and fluid therapy among the dengue patients.  
Early recognition of hypoperfusion and organ failure by the identifying the 
warning sign is crutial to prevent mortality (26). Thus more attention should be put on 
these patients. Expedient and effective crystalloid replacement of fluid loss is essential 
in determining the progress and favourable outcome of the disease (31). We also found 
that in this study, the percentage of platelet reduction between first and second platelet 
count was not significant. It may carry a meaning that platelet count and platelet 
reduction rate were not an indicator of mortality in view of only eight percent of patient 
presented with mucosal ffbleed and coagulation profile showed insignificant results. 
Anyway, we belief that these finding need more evaluation and more study need to be  
One of the strengths of our study was that all dengue infections were confirmed 
by NS1 and/or dengue serology. In contrast, previous reports on dengue mortality often 
depend on serology alone only. Some limitations of this study should be emphasized, 
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especially those related to retrospective study such as small sample size, incomplete 
documentation and missing data.  
 
Conclusion 
Our study demonstrates that clinical manifestation of vomiting/nausea and 
headache have lower risk of mortality whereas laboratory findings of the first and 
second total white count, second platelet count, urea and creatinine were found to be 
independently associated with dengue mortality.  Not all the dengue patients will 
present with the classical warning signs and not all the patients with warning sign will 
have a poor outcome. Unusual clinical presentation of dengue most likely is a reflection 
of a change in the demographic pattern of the population being infected with dengue. 
Early detection of clinical deterioration and prompt treatment are still the main key of 
prevention of death. 
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